The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
Investors understand that their principal will be at very high risk
S&P BSE HEALTH CARE - TRI
AUM ( in Cr.)
portfolio price to book value
Chirag Dagli,Vinit Sambre,Jay Kothari
inception date (regular plan)
expense ratio (regular plan) %
Vedant Asset. All Right Reserved.
Mutual Fund investments are subject to market risks. Read all scheme related documents
carefully. Past performance is not an indicator of future returns. ARN-104974